ENTITY

Verici Dx (VRCI LN)

1
Analysis
Health Care • United States
Verici Dx is an immuno-diagnostics development company focused on prognostic and diagnostic tests for kidney transplant patients. The company develops a suite of proprietary tests including Clarava, Tuteva, and Protega, utilizing AI-assisted transcriptomic analysis to provide RNA signatures for personalized patient and organ response risk. Verici Dx was founded in 2020 and is headquartered in Cardiff, United Kingdom.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x